Katelyn Arnold

Glycan Therapeutics Corporation

NIH Rank #53730
  • Early Career

NIH Funding · FY2024

Total Funding
$55K
Fiscal year 2024
Grants Awarded
1
Active NIH grants
National Rank
#53,730
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $55K across 1 grant · National rank #53730.

Top grants by award amount

Katelyn Arnold's NIH grant portfolio, ranked by award amount.

  • 3R41CA285005-01S1R41
    National I-Corps: Development of synthetic heparin to protect liver graft from ischemia reperfusion injury during transplantation
    $55K
    award amount

Affiliation

Institutions that have administered grants for Katelyn Arnold.

Affiliated with Glycan Therapeutics Corporation (NC).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Glycan Therapeutics Corporation

Related investigators

Other NIH-funded PIs frequently associated with Katelyn Arnold.